DOVA - Dova Pharmaceuticals Inc. (DOVA) CEO David Zaccardelli on Q2 2019 Results - Earnings Call Transcript
Dova Pharmaceuticals, Inc. (DOVA)
Q2 2019 Earnings Conference Call
August 6, 2019 09:00 ET
Company Participants
David Zaccardelli - President and Chief Executive Officer
Mark Hahn - Chief Financial Officer
Jason Hoitt - Chief Commercial Officer
Conference Call Participants
Matt Kaplan - Ladenberg Thalmann
Joe Pantginis - H.C. Wainwright
Presentation
Operator
Good morning and welcome to Dova Pharmaceuticals, Second Quarter 2019 Financial Results and Operating Highlights Conference Call. All lines have been placed in mute to prevent any background noise. Following the speaker's remarks there will be a question and answer session.
Before we begin,